Skip to main content
Clinical Trials/NCT05960877
NCT05960877Not yet recruitingNot Applicable

The Risk Factors of Thrombosis in Complicated Arteriovenous Fistula in Patients on Regular Hemodialysis

Assiut University0 sites69 target enrollmentStarted: December 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
69
Primary Endpoint
Detection of the risk factors of thrombosis in complicated AV Fistula in patients on regular hemodialysis

Study Overview

Brief Summary

study the risk factors of thrombosis in thrombosed arteriovenous fistula in patients on regular hemodialysis

Detailed Description

The number of patients being treated for kidney failure continues to increase every year at a significantly higher rate than that of the world population.

The main renal replacement therapy was hemodialysis (HD) in 57% patients and peritoneal dialysis in 5% patients, while 37% patients underwent a functional kidney transplant.

Native arteriovenous fistula (AVF) is currently the best VA when technically feasible, according to the international dialysis guidelines.

Hemodialysis vascular access failure is the dominant cause of morbidity and the major cost of care for end-stage renal disease (ESRD) patients .

Complications such as thrombosis of VA remain the main problem for many patients with kidney failure.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Cross Sectional

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All patients on maintenance hemodialysis treatment at the dialysis unit of the department of nephrology in Assiut University Hospital .

Exclusion Criteria

  • Patients with known other risk factors of thrombosis, e.g., malignancy, pregnancy, cocs and nephrotic syndrome.

Outcomes

Primary Outcomes

Detection of the risk factors of thrombosis in complicated AV Fistula in patients on regular hemodialysis

Time Frame: 1 week following AV Fistula occlusion

Provide the evidence on the association between potential risk factors and arteriovenous fistula thrombus

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mohamed Aldosouky

Resident doctor

Assiut University

Similar Trials